Related Experiment Video
Updated: Jun 1, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1
Marc Lipsitch1, Lyn Finelli, Richard T Heffernan
1Department of Epidemiology, Harvard School of Public Health, Harvard University, 677 Huntington Ave., Boston, MA 02115, USA. mlipsitc@hsph.harvard.edu
Abstract:
This article synthesizes and extends discussions held during an international meeting on "Surveillance for Decision Making: The Example of 2009 Pandemic Influenza A/H1N1," held at the Center for Communicable Disease Dynamics (CCDD), Harvard School of Public Health, on June 14 and 15, 2010. The meeting involved local, national, and global health authorities and academics representing 7 countries on 4 continents. We define the needs for surveillance in terms of the key decisions that must be made in response to a pandemic: how large a response to mount and which control measures to implement, for whom, and when. In doing so, we specify the quantitative evidence required to make informed decisions. We then describe the sources of surveillance and other population-based data that can presently--or in the future--form the basis for such evidence, and the interpretive tools needed to process raw surveillance data. We describe other inputs to decision making besides epidemiologic and surveillance data, and we conclude with key lessons of the 2009 pandemic for designing and planning surveillance in the future.
Related Concept Videos
Steps in Outbreak Investigation
Influenza
Infectious Diseases and Their Occurrence
Investigation of Disease Outbreaks
Vaccinations
Viral Mutations

